Curatio Healthcare is one of the largest pureplay Indian dermatology company primarily focused on cosmetic dermatology with a portfolio of 50 brands. The company has attained leadership position in pediatric dermatology which contributes c.55% to its total revenue. The company’s portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked amongst top 5 brands in their respective markets. Edelweiss Financial Services acted as the sell-side advisor to Curatio Healthcare Private Limited on its sale of 100% stake to Torrent Pharmaceuticals Limited, the largest deal in the Indian dermatology sector.
Torrent Pharma is a leading global pharmaceutical company with a revenue of c. US$ 1bn* and market cap of US$ 6.5bn. The company has a very strong presence in Indian pharma market – ranks 8th in overall market and amongst top 5 in its key therapy areas which are cardio vascular, gastrointestinal, central nervous system and vitamins, minerals and nutrients. Torrent Pharma has a presence across 40 countries and is ranked #1 among the Indian pharma companies in Brazil, Germany and Philippines.
Edelweiss Financial Services
Advised in the sale of
Curatio Healthcare Private Limited
to